WO2006022723A1 - Means for improving the appearance of mammalian hair and nails - Google Patents
Means for improving the appearance of mammalian hair and nails Download PDFInfo
- Publication number
- WO2006022723A1 WO2006022723A1 PCT/US2004/026842 US2004026842W WO2006022723A1 WO 2006022723 A1 WO2006022723 A1 WO 2006022723A1 US 2004026842 W US2004026842 W US 2004026842W WO 2006022723 A1 WO2006022723 A1 WO 2006022723A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dietary supplement
- hair
- nails
- mammal
- vitamin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
Definitions
- the present invention relates to improving the cosmetic appearance of mammalian hair and/or nails, particularly increasing the shine of mammalian hair and decreasing the breakage of mammalian nails. More particularly, the invention relates to improving the appearance of mammalian hair and/or nails by orally administering a dietary supplement comprising a safe and effective amount of a sugar amine to a mammal, preferably a human.
- Mammalian hair and nails are subject to insults by many extrinsic and intrinsic factors.
- Extrinsic factors include environmental pollution, wind, heat, low humidity, ultraviolet radiation (e.g., from sun exposure), and the like.
- Intrinsic factors include chronological aging and other biochemical changes produced by the body. Additionally, diet and nutrition can have a major impact on the appearance of the hair and nails. In today's society, many people's diets are nutrient deficient and/or imbalanced, resulting in less than optimal hair and nail health and appearance. These extrinsic and intrinsic factors, as well as an insufficient diet, can contribute to hair appearance that is lifeless and dull, rather than attractive and shiny, and to unattractive nails that are brittle and break easily.
- the present invention provides consumers with a means of achieving a more attractive, shinier hair appearance and/or stronger, unbroken, more attractive nails.
- the invention provides for the use of a dietary supplement by a mammal, preferably a human, for the purpose of increasing the appearance of hair shine and/or increasing the attractiveness of the nails by decreasing brittleness and breakage.
- the dietary supplement comprises a safe and effective amount of a sugar amine.
- the present invention provides a method for informing consumers that oral administration of the dietary supplement can increase the attractiveness of the hair and/or nails.
- the invention is directed to an article of commerce. All documents cited herein are incorporated by reference in their entirety; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention.
- safe and effective amount means an amount of a compound or composition sufficient to significantly induce a positive benefit, preferably a positive appearance benefit of the hair and/or nails, but low enough to avoid serious side effects, i.e., to provide a reasonable benefit to risk ratio, within the scope of sound judgment of the skilled artisan.
- the dietary supplement is suitable for oral consumption and is administered orally.
- the dietary supplement is in the form of capsules (e.g., those meant to be swallowed or chewed), tablets (e.g., those meant to be swallowed or chewed), powders (e.g., the powder can be added to water, milk, or another liquid), liquids (e.g., either in ready to drink form or suitable for dilution in another beverage), or nutritional foodstuffs.
- the dietary supplement can be in the form of nutritional bars (e.g., meal or snack bars), cookies, candies (e.g., taffies, caramels, jellies, chocolate melt-aways, chews such as fruit chews, gums), syrups, or beverages (e.g., ready to drink or in the form of concentrates or powders).
- nutritional bars e.g., meal or snack bars
- cookies candies
- taffies e.g., taffies, caramels, jellies, chocolate melt-aways, chews such as fruit chews, gums
- syrups e.g., ready to drink or in the form of concentrates or powders.
- the term "dietary supplement” is broad enough to include not only single dosage forms, but also multiple dosage forms used in conjunction with one another.
- the dietary supplement is a capsule (e.g., containing both omega fatty acids and glucosamine).
- the dietary supplement is two capsules (e.g., one containing omega fatty acids and one containing glucosamine).
- the dietary supplement comprises a beverage containing glucosamine that is consumed in conjunction with a capsule containing omega fatty acids.
- “consumed in conjunction with” or “used in conjunction with” means orally consumed at the same time or at different times.
- the term "improving the appearance of hair and/or nails” includes, but is not limited to, increasing hair shine, luster, and/or radiance; improving and/or increasing nail strength, reducing nail brittleness and/or nail breakage; prevention and/or correction of the functional disorders of the pilo-sebaceous unit of mammals, particularly humans, for instance the treatment of oily and/or hyper-seborrheic scalp, thin hair, hyper-trichosis, and/or alopecia; increasing the density of hair, especially human hair, and/or reducing the heterogeneity of hair diameter and/or improving (e.g., increasing the rate of) the growth of hair and/or nails and/or preventing and/or reducing and/or delaying hair loss; and increasing hair volume.
- heterogeneity of hair diameter refers to a significant variation in the hair diameter in a specific region of the scalp; some hair having a physiological diameter in the range of 100 um, and others, in the nearest proximity of those hairs, having a reduced diameter (e.g., thin hair).
- reducing heterogeneity of the diameter it is meant increasing the diameter of thin hair.
- increasing the density it is meant increasing the number of hairs per square centimeter of skin or scalp.
- the regimen of consumption can vary according to the form of the dietary supplement.
- the dietary supplement is in the form of a capsule or tablet, it is preferably taken orally with one or more meals daily.
- the capsule or tablet may be taken daily with breakfast, lunch, and/or dinner.
- a product suitable for topical application can optionally be applied to the hair and/or nails as part of a combined treatment regimen.
- one or more topical products are applied to the hair and/or nails for the purpose of increasing their health and/or attractiveness, in addition to orally consuming the dietary supplement for the same purpose.
- a combined treatment regimen is not used; rather, the dietary supplement is orally consumed but topical products are not also used for the purpose of improvement in hair and/or nail appearance (e.g., increasing hair shine and/or decreasing nail breakage and/or brittleness).
- the dietary supplement herein comprises: (1) a safe and effective amount of a sugar amine, and (2) optionally, any suitable optional components.
- sucrose amine refers to an amine derivative of a six-carbon sugar.
- sucgar amine is broad enough to include not only sugar amines, but also pharmaceutically acceptable salts thereof.
- sucgar amine and “sugar amines” are used interchangeably to mean one sugar amine or a mixture of more than one sugar amine.
- the daily dose of sugar amine from about O.lg to about 3g, more preferably from about 0.75g to about 2.5g, and still more preferably from about Ig to about 2g.
- sugar amines examples include, but are not limited to, glucosamine, N-acetyl glucosamine, mannosamine, N-acetyl mannosamine, galactosamine, N- acetyl galactosamine; their derivatives; their salts; and mixtures thereof.
- the sugar amine is glucosamine.
- Preferred glucosamines include N-acetyl glucosamine, glucosamine, and glucosamine hydrochloride. Additionally, combinations of two or more sugar amines may be used.
- the dietary supplement according to the present invention can optionally include any suitable optional components.
- These optional components can include, but are not limited to, polyunsaturated fatty acids, anti-oxidants, vitamins, micronutrient metals, pro-biotics, pre-biotics, and combinations thereof.
- the terms "optional component” and “optional components” are used interchangeably to mean one optional component or a mixture of more than one optional component.
- the dietary supplement can include a safe and effective amount of polyunsaturated fatty acids.
- Polyunsaturated fatty acids are essentially polyethylenic acid (i.e., comprising at least two carbon-carbon double bonds).
- the terms "polyunsaturated fatty acid” and “polyunsaturated fatty acids” are used interchangeably to mean one polyunsaturated fatty acid or a mixture of more than one polyunsaturated fatty acid.
- the term “polyunsaturated fatty acids” is broad enough to include mono-, di-, and tri-glycerides, essential fatty acids, salts of fatty acids, and salts of essential fatty acids.
- the polyunsaturated fatty acids used herein are essential fatty acids.
- the terms "essential fatty acid” and “essential fatty acids” are used interchangeably to mean one essential fatty acid or a mixture of more than one essential fatty acid.
- essential fatty acids refers to fats that are essential to the diet because the body cannot produce them and are classified as either omega-3 fatty acids or omega-6 fatty acids.
- the daily dose is from at least about O.lg to about 3g, more preferably from about 0.75g to about 2.5g and, even more preferably, from about Ig to about 2g, of the essential fatty acid.
- omega-3 fatty acids examples include alpha-linolenic acid, stearidonic acid, eicosapentanoic acid, (EPA), docosahexanoic acid (DHA), and mixtures thereof.
- EPA eicosapentanoic acid
- DHA docosahexanoic acid
- the omega-3 fatty acid is EPA, DHA, or mixtures thereof.
- omega-6 fatty acids examples include linoleic acid, gamma- linolenic acid, arachidonic acid, and mixtures thereof.
- the omega-6 fatty acid is gamma-linolenic acid.
- the dietary supplement of the present invention can include a safe and effective amount of an anti-oxidant.
- an anti-oxidant and “anti-oxidants” are used interchangeably to mean one anti-oxidant or a mixture of more than one anti-oxidant.
- the daily dose is from about O.OOOOlg to about Ig, more preferably from about O.OOOlg to about 0.5g and, even more preferably, from about 0.0005g to about O.lg, of the anti-oxidant.
- Anti-oxidants such as ester-C+, ascorbic acid (vitamin C) and its salts, ascorbyl esters of fatty acids, ascorbic acid derivatives (e.g., magnesium ascorbyl phosphate), tocopherol (vitamin E), tocopherol sorbate, tocopherol acetate, other esters of tocopherol, butylated hydroxy benzoic acids and their salts, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (commercially available under the tradename Trolox- ⁇ ), gallic acid and its alkyl esters, especially propyl gallate, uric acid and its salts and alkyl esters, sorbic acid and its salts, lipoic acid, amines (e.g., N 5 N- diethylhydroxylamine, amino-guanidine), sulfhydryl compounds (e.g., glutathione), dihydroxy fumaric acid and its salts, lycine pidolate,
- beta-carotene, lutein, lycopene), tea extracts, grape skin/seed extracts, melanin, and rosemary extracts may be used.
- Preferred anti-oxidants are selected from tocopherol acetate and other esters of tocopherol, more preferably tocopherol acetate.
- the dietary supplement of the present invention can include a safe and effective amount of a vitamin.
- a vitamin and “vitamins” are used interchangeably to mean one vitamin or a mixture of more than one vitamin.
- the terms “vitamin” or “vitamins” are broad enough as used herein to include pro-vitamins (e.g., beta-carotene).
- the daily dose is from about O.OOOOlg to about Ig, more preferably from about O.OOOlg to about 0.5g and, even more preferably, from about 0.0005g to about O.lg, of the vitamin.
- Vitamin B examples include vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K; their derivatives; and mixtures thereof.
- Vitamin B compounds useful herein include vitamin Bi, vitamin B2, vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin Bi 2 , vitamin B] 5 , their derivatives, and mixtures thereof.
- a safe and effective amount of a vitamin B3 compound may be used.
- the daily dose is preferably from about 0.0000 Ig to about Ig, more preferably from about 0.000 Ig to about 0.5g and, even more preferably, from about 0.0005g to about O.lg, of the vitamin B3 compound.
- vitamin B3 compound means a compound having the formula:
- R is - CONH2 (i.e., niacinamide), - COOH (i.e., nicotinic acid) or - CH2OH (i.e., nicotinyl alcohol); derivatives thereof; and salts of any of the foregoing.
- CONH2 i.e., niacinamide
- COOH i.e., nicotinic acid
- CH2OH i.e., nicotinyl alcohol
- Exemplary derivatives of the foregoing vitamin B3 compounds include nicotinic acid esters, including non-vasodilating esters of nicotinic acid (e.g., tocopheryl nicotinate), nicotinyl amino acids, nicotinyl alcohol esters of carboxylic acids, nicotinic acid N-oxide and niacinamide N-oxide.
- nicotinic acid esters including non-vasodilating esters of nicotinic acid (e.g., tocopheryl nicotinate), nicotinyl amino acids, nicotinyl alcohol esters of carboxylic acids, nicotinic acid N-oxide and niacinamide N-oxide.
- vitamin B3 compounds are well known in the art and are commercially available from a number of sources, e.g., the Sigma Chemical Company (St. Louis, MO); ICN Biomedicals, Inc. (Irvin, CA) and Aldrich Chemical Company (Milwaukee, WI).
- the vitamin compounds may be included as the substantially pure material, or as an extract obtained by suitable physical and/or chemical isolation from natural (e.g., plant) sources.
- a safe and effective amount of a vitamin Bg compound may be used.
- the vitamin B 6 compounds useful herein include pyridoxine, esters of pyridoxine (e.g., pyridoxine tripalmitate), amines of pyridoxine (e.g., pyridoxamine), salts of pyridoxine (e.g., pyridoxine HCl) and derivatives thereof, including pyridoxamine, pyridoxal, pyridoxal phosphate, and pyridoxic acid. More preferably, the vitamin B 6 is selected from the group consisting of pyridoxine, esters of pyridoxine and salts of pyridoxine. Most preferably, the vitamin B 6 is pyridoxine HCl.
- Vitamin B 6 can be synthetic or natural in origin and can be used as essentially as pure compounds or mixtures of compounds (e.g., extracts from natural sources or mixtures of synthetic materials). Vitamin B 6 is generally found in many foodstuffs, especially yeast, liver and cereals. As used herein, "vitamin B 6 " includes isomers and tautomers of such and is commercially available from Sigma Chemical Co., St. Louis, MO. When vitamin Be compounds are present in the instant invention, the daily dose is preferably from about O.OOOOlg to about Ig, more preferably from about O.OOOlg to about 0.5g and, even more preferably, from about 0.0005g to about 0. Ig, of the vitamin Bg compound. d. Micronutrient Metals
- the dietary supplement of the present invention may also include a micronutrient metal.
- micronutrient metal and “micronutrient metals” are used interchangeably to mean one micronutrient metal or a mixture of more than one micronutrient metal.
- micronutrient metal refers to a metal that provides nutrients to a mammalian body that are necessary for proper total nutrition.
- the daily dose is from about O.OOOOlg to about Ig, more preferably from about O.OOOlg to about 0.5g and, even more preferably, from about 0.0005g to about O.lg, of micronutrient metal.
- micronutrient metal examples include iron, zinc, selenium, copper, manganese; their derivatives; their salts; and mixtures thereof.
- the micronutrient metal is copper, selenium, zinc and mixtures thereof. e. Pro-biotics
- the dietary supplement may also include a pro-biotic.
- pro-biotic and “pro-biotics” are used interchangeably to mean one pro-biotic or a mixture of more than one pro-biotic.
- pro-biotic refers to an organism that contributes to the health and balance of the intestinal tract.
- the daily dose is from about O.OOOOlg to about Ig, more preferably from about O.OOOlg to about 0.5g, and even more preferably from about 0.0005g to about O.lg of pro-biotic.
- Preferred pro-biotics can include Lactobacilli and Bifidobacteria. f.
- the dietary supplement of the present invention may also include a pre-biotic.
- pre-biotic and “pre-biotics” are broad enough to include one or a mixture of more than one pre-biotics.
- pre-biotic refers to a substrate on which bacteria (i.e., pro-biotic) feeds.
- the daily dose is from about O.OOOOlg to about Ig, more preferably from about O.OOOlg to about 0.5g and, even more preferably, from about 0.0005g to about O.lg, of the pre-biotic.
- pre-biotics useful herein include inulin and fructooligosaccharides and mixtures thereof.
- the present invention provides a method for improving human hair and/or nail appearance.
- the method comprises the steps of: (1) making available to a consumer an orally administered dietary supplement comprising a safe and effective amount of a sugar amine;
- the dietary supplement can be made available to the consumer by any suitable means. For instance, it can be offered for sale at a retail outlet or for purchase through a catalogue or via the internet. Furthermore, any suitable means of communication can be used to communicate to the consumer that oral administration of the dietary supplement can improve the appearance of the consumer's hair or nails. For example, communication can be in the form of printed material, an electronic message via the internet, or a broadcast message through television or radio. The communication can inform the consumer that oral administration of the dietary supplement can improve hair health, hair shine, hair luster, or hair radiance, or can improve nail health, nail strength, or can reduce nail brittleness or breakage.
- the communication informs the consumer that oral administration of the dietary supplement can lead to prevention and/or correction of the functional disorders of the pilo-sebaceous unit of mammals, particularly humans, and more specifically for the treatment of oily and/or hyper-seborrheic scalp, thin hair, hyper-trichosis, and/or alopecia.
- the communication informs the consumer that oral administration of the dietary supplement can increase the density of hair, especially human hair, and/or reduce the heterogeneity of their diameter and/or improve their growth and/or prevent and/or reduce and/or delay hair loss.
- the communication informs the consumer that oral administration of the dietary supplement can increase the hair volume.
- heterogeneity of hair diameter refers to a significant variation in the hair diameter in a specific region of the scalp; some hair having a physiological diameter in the range of 100 um, and others, in the nearest proximity of those hairs, having a reduced diameter (e.g., thin hair).
- reducing heterogeneity of the diameter it is meant increasing the diameter of thin hair.
- increasing the density it is meant increasing the number of hairs per square centimeter of skin or scalp.
- the consumer can acquire the dietary supplement by any suitable means.
- the consumer can purchase the dietary supplement, can obtain the dietary supplement from a purchaser of the dietary supplement, can obtain the dietary supplement as a free sample, or can obtain the dietary supplement as a gift with, or in conjunction with, the purchase of another item.
- the term "consumer" is broad enough to include both purchasers and potential purchasers of the dietary supplement.
- the invention is directed to an article of commerce.
- the article of commerce comprises:
- an orally administered dietary supplement comprising a safe and effective amount of a sugar amine
- Suitable messages can include, but are not limited to, messages that inform the consumer that oral administration of the dietary supplement can improve hair health, hair shine, hair luster, or hair radiance, or can improve nail health, nail strength, or can reduce nail brittleness or breakage.
- the message can be printed material attached directly or indirectly to the container, attached directly or indirectly near the container, or alternatively can be a printed, electronic, or broadcast message associated with the dietary supplement.
- Suitable containers include, but are not limited to, bottles, boxes, bags, and pouches.
- the dietary supplement of this example comprises three separate capsules.
- the capsule is formulated according to the following:
- the dietary supplement of Example 1 is packaged in a bottle and offered for sale in a retail outlet.
- a television advertisement contains information that informs a consumer that oral administration of the dietary supplement can improve the shine, radiance, and luster of the consumer's hair.
- the dietary supplement of Example 1 is packaged in a pouch and offered for sale in a retail outlet.
- a print advertisement in a magazine contains information that informs a consumer that oral administration of the dietary supplement can decrease breakage and brittleness of the consumer's nails.
- the dietary supplement of Example 1 is packaged in a pouch and offered for sale in a retail outlet.
- a print advertisement in a magazine contains information that informs a consumer that oral administration of the dietary supplement can improve the appearance of both the hair and nails by increasing the shine of the consumer's hair and decreasing breakage of the consumer's nails.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2004800438082A CN101001542A (en) | 2004-08-18 | 2004-08-18 | Means for improving the appearance of mammalian hair and nails |
EP04816812A EP1786278A1 (en) | 2004-08-18 | 2004-08-18 | Means for improving the appearance of mammalian hair and nails |
PCT/US2004/026842 WO2006022723A1 (en) | 2004-08-18 | 2004-08-18 | Means for improving the appearance of mammalian hair and nails |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/026842 WO2006022723A1 (en) | 2004-08-18 | 2004-08-18 | Means for improving the appearance of mammalian hair and nails |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006022723A1 true WO2006022723A1 (en) | 2006-03-02 |
Family
ID=35967792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/026842 WO2006022723A1 (en) | 2004-08-18 | 2004-08-18 | Means for improving the appearance of mammalian hair and nails |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1786278A1 (en) |
CN (1) | CN101001542A (en) |
WO (1) | WO2006022723A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3005411B1 (en) * | 2013-05-07 | 2016-09-30 | Laboratoires Inneov | ASSOCIATION OF ACTIVE INGREDIENTS FOR ORAL ADMINISTRATION TO ENHANCE THE QUALITY OF NAILS. |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001012151A1 (en) * | 1999-08-12 | 2001-02-22 | Paul Rodney Clayton | Skin care product |
US20020098253A1 (en) * | 1996-02-23 | 2002-07-25 | Riley Patricia A. | Oral compositions containing lotus |
US6660308B1 (en) * | 2002-09-11 | 2003-12-09 | Kenneth A. Martin | Beverage and additive for the ill |
US20040071752A1 (en) * | 1999-11-06 | 2004-04-15 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
WO2004068970A2 (en) * | 2003-01-31 | 2004-08-19 | The Procter & Gamble Company | Means for improving the appearance of mammalian keratinous tissue |
-
2004
- 2004-08-18 WO PCT/US2004/026842 patent/WO2006022723A1/en active Application Filing
- 2004-08-18 CN CNA2004800438082A patent/CN101001542A/en active Pending
- 2004-08-18 EP EP04816812A patent/EP1786278A1/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020098253A1 (en) * | 1996-02-23 | 2002-07-25 | Riley Patricia A. | Oral compositions containing lotus |
WO2001012151A1 (en) * | 1999-08-12 | 2001-02-22 | Paul Rodney Clayton | Skin care product |
US20040071752A1 (en) * | 1999-11-06 | 2004-04-15 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
US6660308B1 (en) * | 2002-09-11 | 2003-12-09 | Kenneth A. Martin | Beverage and additive for the ill |
WO2004068970A2 (en) * | 2003-01-31 | 2004-08-19 | The Procter & Gamble Company | Means for improving the appearance of mammalian keratinous tissue |
Also Published As
Publication number | Publication date |
---|---|
CN101001542A (en) | 2007-07-18 |
EP1786278A1 (en) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1871485B1 (en) | Use of an orally administered dietary supplement for regulating the cosmetic appearance of human keratinous tissue | |
Lutter et al. | Proposed nutrient composition for fortified complementary foods | |
CA2451704C (en) | Fortified rice bran food product and method for promoting cardiovascular health | |
US20130017182A1 (en) | Multi-criteria optimized dietary supplement formulations | |
Wagh et al. | Ready to use therapeutic food (RUTF): an overview | |
US20100093844A1 (en) | Oral composition for enhancing skin properties | |
US20200316114A1 (en) | Hair restorer preparation or food supplement | |
US20050123500A1 (en) | Means for improving the appearance of mammalian hair and nails | |
Wagner et al. | The role of fortified foods–situation in Austria | |
WO2006022723A1 (en) | Means for improving the appearance of mammalian hair and nails | |
Adu‐Afarwuah | Impact of nutrient supplementation on maternal nutrition and child growth and development in Sub‐Saharan Africa: The case of small‐quantity lipid‐based nutrient supplements | |
TW201141466A (en) | Methods of modulating inflammation in preterm infants using carotenoids | |
Khurana et al. | Iron fortification | |
Rao et al. | A review on dietary supplements: Delivery systems, applications and regulations | |
Moriyama et al. | Royal Jelly in medicinal to functional energy drinks | |
EP2398449B1 (en) | Edible composition for treating cutaneous signs of ageing | |
Code | Active Multi Vite Gummies | |
Tuttle | Composition of energy drinks | |
Niharika et al. | Development of Super Food Nutri Rich Bar | |
AU2002320118B2 (en) | Fortified ricebran food product and method for promoting cardiovascular health | |
US20100215807A1 (en) | Uncooked and fortified food composition | |
Furber | Nutrition, Diet, and Supplements for Peak Physical & Mental Performance | |
US20180160697A1 (en) | Nutritional additive composition | |
CN1397188A (en) | Functional nutrient combined coffee for women | |
CoEnzyme | CoEnzyme Q· 10 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004816812 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200480043808.2 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2004816812 Country of ref document: EP |